Global Oncology Nutrition Deals Market Growth (Status and Outlook) 2023-2029
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- 1.8 Market Estimation Caveats
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Oncology Nutrition Deals Market Size 2018-2029
- 2.1.2 Oncology Nutrition Deals Market Size CAGR by Region 2018 VS 2022 VS 2029
- 2.2 Oncology Nutrition Deals Segment by Type
- 2.2.1 Enteral Nutrition
- 2.2.2 Parenteral Nutrition
- 2.3 Oncology Nutrition Deals Market Size by Type
- 2.3.1 Oncology Nutrition Deals Market Size CAGR by Type (2018 VS 2022 VS 2029)
- 2.3.2 Global Oncology Nutrition Deals Market Size Market Share by Type (2018-2023)
- 2.4 Oncology Nutrition Deals Segment by Application
- 2.4.1 Hospitals
- 2.4.2 Homecare
- 2.4.3 Specialty Clinics
- 2.5 Oncology Nutrition Deals Market Size by Application
- 2.5.1 Oncology Nutrition Deals Market Size CAGR by Application (2018 VS 2022 VS 2029)
- 2.5.2 Global Oncology Nutrition Deals Market Size Market Share by Application (2018-2023)
3 Oncology Nutrition Deals Market Size by Player
- 3.1 Oncology Nutrition Deals Market Size Market Share by Players
- 3.1.1 Global Oncology Nutrition Deals Revenue by Players (2018-2023)
- 3.1.2 Global Oncology Nutrition Deals Revenue Market Share by Players (2018-2023)
- 3.2 Global Oncology Nutrition Deals Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Oncology Nutrition Deals by Regions
- 4.1 Oncology Nutrition Deals Market Size by Regions (2018-2023)
- 4.2 Americas Oncology Nutrition Deals Market Size Growth (2018-2023)
- 4.3 APAC Oncology Nutrition Deals Market Size Growth (2018-2023)
- 4.4 Europe Oncology Nutrition Deals Market Size Growth (2018-2023)
- 4.5 Middle East & Africa Oncology Nutrition Deals Market Size Growth (2018-2023)
5 Americas
- 5.1 Americas Oncology Nutrition Deals Market Size by Country (2018-2023)
- 5.2 Americas Oncology Nutrition Deals Market Size by Type (2018-2023)
- 5.3 Americas Oncology Nutrition Deals Market Size by Application (2018-2023)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Oncology Nutrition Deals Market Size by Region (2018-2023)
- 6.2 APAC Oncology Nutrition Deals Market Size by Type (2018-2023)
- 6.3 APAC Oncology Nutrition Deals Market Size by Application (2018-2023)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Oncology Nutrition Deals by Country (2018-2023)
- 7.2 Europe Oncology Nutrition Deals Market Size by Type (2018-2023)
- 7.3 Europe Oncology Nutrition Deals Market Size by Application (2018-2023)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Oncology Nutrition Deals by Region (2018-2023)
- 8.2 Middle East & Africa Oncology Nutrition Deals Market Size by Type (2018-2023)
- 8.3 Middle East & Africa Oncology Nutrition Deals Market Size by Application (2018-2023)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Oncology Nutrition Deals Market Forecast
- 10.1 Global Oncology Nutrition Deals Forecast by Regions (2024-2029)
- 10.1.1 Global Oncology Nutrition Deals Forecast by Regions (2024-2029)
- 10.1.2 Americas Oncology Nutrition Deals Forecast
- 10.1.3 APAC Oncology Nutrition Deals Forecast
- 10.1.4 Europe Oncology Nutrition Deals Forecast
- 10.1.5 Middle East & Africa Oncology Nutrition Deals Forecast
- 10.2 Americas Oncology Nutrition Deals Forecast by Country (2024-2029)
- 10.2.1 United States Oncology Nutrition Deals Market Forecast
- 10.2.2 Canada Oncology Nutrition Deals Market Forecast
- 10.2.3 Mexico Oncology Nutrition Deals Market Forecast
- 10.2.4 Brazil Oncology Nutrition Deals Market Forecast
- 10.3 APAC Oncology Nutrition Deals Forecast by Region (2024-2029)
- 10.3.1 China Oncology Nutrition Deals Market Forecast
- 10.3.2 Japan Oncology Nutrition Deals Market Forecast
- 10.3.3 Korea Oncology Nutrition Deals Market Forecast
- 10.3.4 Southeast Asia Oncology Nutrition Deals Market Forecast
- 10.3.5 India Oncology Nutrition Deals Market Forecast
- 10.3.6 Australia Oncology Nutrition Deals Market Forecast
- 10.4 Europe Oncology Nutrition Deals Forecast by Country (2024-2029)
- 10.4.1 Germany Oncology Nutrition Deals Market Forecast
- 10.4.2 France Oncology Nutrition Deals Market Forecast
- 10.4.3 UK Oncology Nutrition Deals Market Forecast
- 10.4.4 Italy Oncology Nutrition Deals Market Forecast
- 10.4.5 Russia Oncology Nutrition Deals Market Forecast
- 10.5 Middle East & Africa Oncology Nutrition Deals Forecast by Region (2024-2029)
- 10.5.1 Egypt Oncology Nutrition Deals Market Forecast
- 10.5.2 South Africa Oncology Nutrition Deals Market Forecast
- 10.5.3 Israel Oncology Nutrition Deals Market Forecast
- 10.5.4 Turkey Oncology Nutrition Deals Market Forecast
- 10.5.5 GCC Countries Oncology Nutrition Deals Market Forecast
- 10.6 Global Oncology Nutrition Deals Forecast by Type (2024-2029)
- 10.7 Global Oncology Nutrition Deals Forecast by Application (2024-2029)
11 Key Players Analysis
- 11.1 Abbott Laboratories
- 11.1.1 Abbott Laboratories Company Information
- 11.1.2 Abbott Laboratories Oncology Nutrition Deals Product Offered
- 11.1.3 Abbott Laboratories Oncology Nutrition Deals Revenue, Gross Margin and Market Share (2018-2023)
- 11.1.4 Abbott Laboratories Main Business Overview
- 11.1.5 Abbott Laboratories Latest Developments
- 11.2 Ajinomoto Cambrooke
- 11.2.1 Ajinomoto Cambrooke Company Information
- 11.2.2 Ajinomoto Cambrooke Oncology Nutrition Deals Product Offered
- 11.2.3 Ajinomoto Cambrooke Oncology Nutrition Deals Revenue, Gross Margin and Market Share (2018-2023)
- 11.2.4 Ajinomoto Cambrooke Main Business Overview
- 11.2.5 Ajinomoto Cambrooke Latest Developments
- 11.3 Aceto
- 11.3.1 Aceto Company Information
- 11.3.2 Aceto Oncology Nutrition Deals Product Offered
- 11.3.3 Aceto Oncology Nutrition Deals Revenue, Gross Margin and Market Share (2018-2023)
- 11.3.4 Aceto Main Business Overview
- 11.3.5 Aceto Latest Developments
- 11.4 American Society for Parenteral and Enteral Nutrition (ASPEN)
- 11.4.1 American Society for Parenteral and Enteral Nutrition (ASPEN) Company Information
- 11.4.2 American Society for Parenteral and Enteral Nutrition (ASPEN) Oncology Nutrition Deals Product Offered
- 11.4.3 American Society for Parenteral and Enteral Nutrition (ASPEN) Oncology Nutrition Deals Revenue, Gross Margin and Market Share (2018-2023)
- 11.4.4 American Society for Parenteral and Enteral Nutrition (ASPEN) Main Business Overview
- 11.4.5 American Society for Parenteral and Enteral Nutrition (ASPEN) Latest Developments
- 11.5 Baxter
- 11.5.1 Baxter Company Information
- 11.5.2 Baxter Oncology Nutrition Deals Product Offered
- 11.5.3 Baxter Oncology Nutrition Deals Revenue, Gross Margin and Market Share (2018-2023)
- 11.5.4 Baxter Main Business Overview
- 11.5.5 Baxter Latest Developments
- 11.6 Danone Nutricia
- 11.6.1 Danone Nutricia Company Information
- 11.6.2 Danone Nutricia Oncology Nutrition Deals Product Offered
- 11.6.3 Danone Nutricia Oncology Nutrition Deals Revenue, Gross Margin and Market Share (2018-2023)
- 11.6.4 Danone Nutricia Main Business Overview
- 11.6.5 Danone Nutricia Latest Developments
- 11.7 Fresenius Kabi AG
- 11.7.1 Fresenius Kabi AG Company Information
- 11.7.2 Fresenius Kabi AG Oncology Nutrition Deals Product Offered
- 11.7.3 Fresenius Kabi AG Oncology Nutrition Deals Revenue, Gross Margin and Market Share (2018-2023)
- 11.7.4 Fresenius Kabi AG Main Business Overview
- 11.7.5 Fresenius Kabi AG Latest Developments
- 11.8 FMC Corporation
- 11.8.1 FMC Corporation Company Information
- 11.8.2 FMC Corporation Oncology Nutrition Deals Product Offered
- 11.8.3 FMC Corporation Oncology Nutrition Deals Revenue, Gross Margin and Market Share (2018-2023)
- 11.8.4 FMC Corporation Main Business Overview
- 11.8.5 FMC Corporation Latest Developments
- 11.9 Global Health Products, Inc
- 11.9.1 Global Health Products, Inc Company Information
- 11.9.2 Global Health Products, Inc Oncology Nutrition Deals Product Offered
- 11.9.3 Global Health Products, Inc Oncology Nutrition Deals Revenue, Gross Margin and Market Share (2018-2023)
- 11.9.4 Global Health Products, Inc Main Business Overview
- 11.9.5 Global Health Products, Inc Latest Developments
- 11.10 Koninklijke DSM N.V.
- 11.10.1 Koninklijke DSM N.V. Company Information
- 11.10.2 Koninklijke DSM N.V. Oncology Nutrition Deals Product Offered
- 11.10.3 Koninklijke DSM N.V. Oncology Nutrition Deals Revenue, Gross Margin and Market Share (2018-2023)
- 11.10.4 Koninklijke DSM N.V. Main Business Overview
- 11.10.5 Koninklijke DSM N.V. Latest Developments
- 11.11 Mead Johnson & Company, LLC
- 11.11.1 Mead Johnson & Company, LLC Company Information
- 11.11.2 Mead Johnson & Company, LLC Oncology Nutrition Deals Product Offered
- 11.11.3 Mead Johnson & Company, LLC Oncology Nutrition Deals Revenue, Gross Margin and Market Share (2018-2023)
- 11.11.4 Mead Johnson & Company, LLC Main Business Overview
- 11.11.5 Mead Johnson & Company, LLC Latest Developments
- 11.12 Nestle Health Science
- 11.12.1 Nestle Health Science Company Information
- 11.12.2 Nestle Health Science Oncology Nutrition Deals Product Offered
- 11.12.3 Nestle Health Science Oncology Nutrition Deals Revenue, Gross Margin and Market Share (2018-2023)
- 11.12.4 Nestle Health Science Main Business Overview
- 11.12.5 Nestle Health Science Latest Developments
- 11.13 Smartfish AS
- 11.13.1 Smartfish AS Company Information
- 11.13.2 Smartfish AS Oncology Nutrition Deals Product Offered
- 11.13.3 Smartfish AS Oncology Nutrition Deals Revenue, Gross Margin and Market Share (2018-2023)
- 11.13.4 Smartfish AS Main Business Overview
- 11.13.5 Smartfish AS Latest Developments
12 Research Findings and Conclusion
The global Oncology Nutrition Deals market size is projected to grow from US$ 1232.6 million in 2022 to US$ 2723.5 million in 2029; it is expected to grow at a CAGR of 12.0% from 2023 to 2029.
The rising incidence of cancer and increasing expenditure on healthcare due to changing lifestyles are expected to drive the growth of this market. Moreover, increasing investment in research and continuous development in technology and treatment are opportunities for players operating in the oncology nutrition market. On the other hand, a lack of knowledge and understanding regarding oncology nutrition can hinder its growth.
Oncology nutrition deals with managing the nutritional intake of patients suffering from cancer to support the treatment and reduce its side effects. The oncology nutrition market can be classified based on the type of cancer, which includes lung cancer, head and neck cancer, stomach cancers, liver cancer, blood cancer, and others; by nutrition, including enteral nutrition and parenteral nutrition.
LPI (LP Information)' newest research report, the “Oncology Nutrition Deals Industry Forecast” looks at past sales and reviews total world Oncology Nutrition Deals sales in 2022, providing a comprehensive analysis by region and market sector of projected Oncology Nutrition Deals sales for 2023 through 2029. With Oncology Nutrition Deals sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oncology Nutrition Deals industry.
This Insight Report provides a comprehensive analysis of the global Oncology Nutrition Deals landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oncology Nutrition Deals portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oncology Nutrition Deals market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oncology Nutrition Deals and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oncology Nutrition Deals.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncology Nutrition Deals market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Enteral Nutrition
Parenteral Nutrition
Segmentation by application
Hospitals
Homecare
Specialty Clinics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
Ajinomoto Cambrooke
Aceto
American Society for Parenteral and Enteral Nutrition (ASPEN)
Baxter
Danone Nutricia
Fresenius Kabi AG
FMC Corporation
Global Health Products, Inc
Koninklijke DSM N.V.
Mead Johnson & Company, LLC
Nestle Health Science
Smartfish AS